FURTHER STRONG GROWTH IN ANNUAL RESULTS FOR THE 2025 FINANCIAL YEAR. Solid growth in activity of +8.5% in 2025 to €50 million, driven by sustained international development and ...

if (age >= 12 && height > 150 ) { if ( age < 15 ) { if (hasAdult) { std::cout << "You can ride with adult supervision!" << std::endl; } else { std::cout << "Sorry ...

Sarepta Therapeutics now sits on an updated fair value estimate of US$21.65 per share, compared with the prior US$20.61, reflecting fresh inputs to analysts’ models. Behind that shift, research views ...

Chicane Capital I Corp. (TSXV: CCIC.P) (“Chicane”) is pleased to announce that it has entered into a binding letter of intent ...

Plato Gold Corp. ("Plato" or the "Company") announces that it has closed the transaction (the "Transaction") annouced on April 2, 2026 with Mayfair Gold Corp. ("Mayfair") pursuant to which Mayfair has ...

Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces today the appointment of Christoph Korpus, PhD, MBA, as Chief ...

Explore the recent advances in fuzzing, including the challenges and opportunities it presents for high-integrity software ...

Senior leadership roles at Guardant Health, Genentech and PfizerRegulatory, clinical and commercial expertise in therapeutics and biomarkersWill assist with osteosarcoma regulatory advice and oncology ...

Resulting Issuer to Close C$3.5M Concurrent Financing and Apply to List on the Canadian Securities Exchange US$750,000 Bridge Loan Has Been Advanced from Cora to Tiger Vancouver, BC and San Juan, ...

The North West Company Inc. (the "Company" or "North West") today announces its unaudited financial results for the fourth quarter ended January 31, 2026 and released its 2025 Annual Report and Annual ...

Co-founder of more than 40 biotechnology companies, including 16 IPOs and 19 successful acquisitions Scientific and medical titan focused on driving innovation for human healthWill assist with listeri ...

Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.